Clinical Trial Update: FMT to Convert Response to Immunotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at The Netherlands Cancer Institute is evaluating fecal microbiota transplant to convert response to immunotherapy in melanoma patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Melanoma Stage III, Melanoma Stage IV | Phase 1, Phase 2 | Status: RECRUITING